Pharma News

BioMap, a leading company in the field of life sciences, has announced a breakthrough strategic partnership with Sanofi aimed at jointly developing artificial intelligence (AI) models to accelerate the research and development of biotherapeutic drugs.

• BioMap

Sihuan Pharmaceutical Holdings Group Ltd., a leading pharmaceutical company, is delighted to announce its selection as one of the first echelon of enterprises in "The list of China's Top 100 Pharmaceutical Innovative Enterprises in 2023.

• Innovation

On October 11th, Tempest Therapeutics made a groundbreaking announcement regarding their Phase Ib/II study on TPST-1120, a PPAR⍺ antagonist, for patients with unresectable or metastatic hepatocellular carcinoma (HCC).

• Tempest

India, known as the "pharmacy of the world," had embarked on an ambitious plan in 2022 to reduce its dependence on China for key raw materials in the pharmaceutical sector.

• India

On September 25th, Weichai and Bojian jointly announced that Leqembi injection (200mg, 500mg, lecanemab) has been approved in Japan for the treatment of mild cognitive impairment (MCI) and mild dementia caused by Alzheimer's disease (AD).

• Leqembi

On August 1st, Hansoh Pharma announced that the Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA) has accepted the biologics license application (BLA) for zolbetuximab.

• Zolbetuximab

Recently, Eli Lilly announced the results of two phase 3 clinical trials of Tirzepatide, showing that the average weight loss effect reached 26.6%, making it the most effective weight loss drug in history.

• weight loss

GlaxoSmithKline Pharmaceuticals, the Indian unit of UK-based GSK plc, has reported an 11% rise in its Q1 2023 profit, driven by strong demand for its vaccines.

• Vaccine
• GlaxoSmithKline

Egyptian Pharmaceutical Market General Overview

• pharmaceutical trend

In a recent report released by the United States Department of Agriculture (USDA), it has been suggested that the coronavirus may have spread widely in deer populations and could potentially spread back to humans.

• coronavirus

2023 has been a year of continuous events in the medical field.

• medical event

On July 10th, Hengrui Medicine announced that its subsidiary, Tianjin Hengrui Medicine Co., Ltd., has received the drug clinical trial approval notification issued by the National Medical Products Administration for HRS-4357 injection.

• clinical trial

Betta Pharmaceuticals and C4 Therapeutics have jointly developed CFT8919, an orally bioavailable BiDAC™ degrader designed to selectively combat EGFRL858R in non-small cell lung cancer (NSCLC) patients.

• cft8919

The cellulose ether market has been on the rise in recent years, driven by the demand for high-quality medical excipients in the pharmaceutical industry.

• cellulose ether

"Drug Registration Certificate" issued by the National Medical Products Administration (NMPA) for the application of market approval of Liru Ping® injection for the indications of obesity or overweight.

• fat
• overweight
• obesity

Japan is expected to receive the final report from the United Nations regulatory agency on Tuesday (July 4th), approving the plan to discharge over 1.3 million tons of treated Fukushima nuclear disaster water into the Pacific Ocean over the next 30 years.

• nuclear
• pollution

Elon Musk, the CEO of Twitter and SpaceX, has reportedly been using small doses of the psychedelic drug ketamine to treat depression, while also consuming larger doses during social gatherings, according to a report in The Wall Street Journal.

• Elon Musk
• ketamine

New developments of CAR-T therapy.

• CAR-T

RC108, a new drug targeting c-Met and RemeGen ADC combined with PD-1, has been approved for the treatment of solid tumors in phase Ⅰb/Ⅱ clinical trial.

• c-Met
• ADC
• PD-1

The first-of-its-kind ADC of CSPC was granted fast track status by FDA.

• ADC